New cancer vaccine raises hopes
Full story
A new cancer vaccine uses genetic sequencing from a patient's cancer cells after a tumor is surgically removed. This treatment aims to lower the risk of cancer returning in patients who had high-risk melanoma removed. It may lead to a substantial increase in survival chances.
A cancer vaccine developed using genetic sequencing of a patient's cancer cells after surgical removal of a tumor is raising hopes that it may be possible to significantly reduce the risk of cancer recurrence in patients who have had high-risk melanoma removed. The treatment could substantially improve their chances of survival.